CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
152 hedge funds and large institutions have $2.41B invested in Clovis Oncology, Inc. in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 53 increasing their positions, 48 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more funds holding
Funds holding: 143 → 152 (+9)
55% less call options, than puts
Call options by funds: $22.7M | Put options by funds: $50.5M
Holders
152
Holding in Top 10
11
Calls
$22.7M
Puts
$50.5M
Top Buyers
| 1 | +$40.2M | |
| 2 | +$21.4M | |
| 3 | +$21.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.1M |
Top Sellers
| 1 | -$27.7M | |
| 2 | -$23.3M | |
| 3 | -$20.8M | |
| 4 |
VAM
Visium Asset Management
New York
|
-$20.1M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$16.6M |